| Name | Title | Contact Details |
|---|
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
PetDx® – The Liquid Biopsy Company for Pets™ is a molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health.
IncludeHealth is a digital health and performance company delivering next-generation musculoskeletal care and training. Offered through a monthly subscription, their platform provides a comprehensive digital suite that pairs HIPAA compliant cloud software with connected equipment, sensors and data to quantify and qualify human performance. This unique pairing provides breakthrough capabilities such as centralized and standardized protocols, outcomes-based data collection, autonomous instruction and documentation, and location agnostic delivery to produce better outcomes with lower costs. The proprietary technology at IncludeHealth has been recognized with 28 international innovation and health awards and is utilized in orthopedics, neuroscience, pediatric care, senior care, government, and general wellness facilities.
The Wound Pros, LLC is a physician-owned Medicare Part B supplier of the industry’s most advanced wound care dressings. As a bonus, Wound Pros offers excellent clinical expertise which gives our patients the best opportunity to heal efficiently. Our vision is to change the way the world treats and manages non-healing wounds. Chronic non-healing wounds can compromise the quality of life for those living in long-term care facilities. The longer a wound remains open or unhealed, the greater the chance of unwanted complications such as infection, hospitalisation, and even amputation. At The Wound Pros, we are dedicated to meeting this challenge head-on with our "Hi-Tech Hi-Touch Approach” to wound care management. Our vision is to change the way the world treats and manages chronic non-healing wounds with better data, better decision making and better documentation.
Mercy Retirement and Care Center, a nonprofit organization, has been providing quality compassionate care and services to older adults for more than 130 years. Supportive residential, assisted living, dementia care and skilled nursing programs are offered